Evidence map›Paper›PMID 24928990›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.

Jinzhu Li, Sarah K Figueira, Alexandra C A Vrazo, Brock F Binkowski, Braeden L Butler, Yasuhiro Tabata, Alexandra Filipovich, Michael B Jordan, Kimberly A Risma

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The Expanding Arsenal of Cytotoxic T Cells.Frontiers in immunology · 2022
    Review
  6. Cytotoxic Efficiency of Human CD8Frontiers in immunology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Imaging Proteolytic Activities in Mouse Models of Cancer.Methods in molecular biology (Clifton, N.J.) · 2018
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jinzhu LiDivision of Allergy/Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229;
Sarah K FigueiraDivision of Allergy/Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229;
Alexandra C A VrazoDivision of Allergy/Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229;
Brock F BinkowskiPromega Corp., Madison, WI 53704;
Braeden L ButlerPromega Corp., Madison, WI 53704;
Yasuhiro TabataDivision of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229;
Alexandra FilipovichDivision of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and.
Michael B JordanDivision of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Kimberly A RismaDivision of Allergy/Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and Kimberly.Risma@cchmc.org.
Cincinnati Children's Hospital Medical Center · USPromega (United States) · USUniversity of Cincinnati Medical Center · US

Funding

Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., TSEVAT, JOEL · 2012 to 2014
$9.9M
Immunology/Allergy Fellowship Training GrantT32AI060515 · NIAID · UNIVERSITY OF CINCINNATI · PI BERNSTEIN, DAVID I., ROTHENBERG, MARC E. · 2004 to 2018
$2.8M
NCATS NIH HHS 8 UL1 TR000077-05NCATS NIH HHS UL1 TR000077NIAID NIH HHS T32 AI-060515NIAID NIH HHS T32 AI060515
6 · The paper itself

Abstract

Activation of caspase-mediated apoptosis is reported to be a hallmark of both granzyme B- and Fas-mediated pathways of killing by CTLs; however, the kinetics of caspase activation remain undefined owing to an inability to monitor target cell-specific apoptosis in real time. We have overcome this limitation by developing a novel biosensor assay that detects continuous, protease-specific activity in target cells. Biosensors were engineered from a circularly permuted luciferase, linked internally by either caspase 3/7 or granzyme B/caspase 8 cleavage sites, thus allowing activation upon proteolytic cleavage by the respective proteases. Coincubation of murine CTLs with target cells expressing either type of biosensor led to a robust luminescent signal within minutes of cell contact. The signal was modulated by the strength of TCR signaling, the ratio of CTL/target cells, and the type of biosensor used. Additionally, the luciferase signal at 30 min correlated with target cell death, as measured by a (51)Cr-release assay. The rate of caspase 3/7 biosensor activation was unexpectedly rapid following granzyme B- compared with Fas-mediated signal induction in murine CTLs; the latter appeared gradually after a 90-min delay in perforin- or granzyme B-deficient CTLs. Remarkably, the Fas-dependent, caspase 3/7 biosensor signal induced by perforin-deficient human CTLs was also detectable after a 90-min delay when measured by redirected killing. Thus, we have used a novel, real-time assay to demonstrate the distinct pattern of caspase activation induced by granzyme B versus Fas in human and murine CTLs.

Indexed as

AnimalsApoptosisBinding SitesCaspase 3Caspase 7CaspasesCell Line, TumorCytotoxicity, ImmunologicCytotoxicity Tests, ImmunologicEnzyme Activationfas ReceptorGranzymesHumansLuciferasesLuminescent MeasurementsMiceCaspase 3Caspase 7Caspasesfas ReceptorGranzymesLuciferasesPerforin

Identifiers

PMID24928990
PMCPMC4107314
OpenAlexW1684584920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.